Results 301 to 310 of about 3,067,002 (353)

Lung Transplant

Critical Care Nursing Clinics of North America, 2011
The ICU period is only one time point among many in the complex, multidisciplinary postoperative management required for patient survival and improved QOL. The care required on step-down units and after discharge to home each has unique care aspects that impact successful patient outcomes.
Elisabeth L, George, Jane, Guttendorf
openaire   +2 more sources

Lung transplantation for cystic fibrosis.

The Journal of Heart and Lung Transplantation, 2020
BACKGROUND The contribution of lung transplantation to the treatment of patients with end-stage cystic fibrosis (CF) has been debated. We aimed to describe achievable outcomes from high-volume CF and lung transplant programs.
J. Yeung, T. Machuca, C. Chaparro, M. Cypel, A. Stephenson, M. Solomon, Tomohito Saito, M. Binnie, C. Chow, H. Grasemann, A. Pierre, K. Yasufuku, M. de Perrot, L. Donahoe, J. Tikkanen, T. Martinu, T. Waddell, E. Tullis, L. Singer, S. Keshavjee   +19 more
semanticscholar   +1 more source

Lung transplantation for idiopathic pulmonary fibrosis.

The Lancet Respiratory Medicine, 2019
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis. Lung transplantation is the only intervention shown to increase life expectancy for patients with IPF, but it is associated with disease-specific challenges. In this
P. George, C. Patterson, A. Reed, M. Thillai   +3 more
semanticscholar   +1 more source

Overview of Lung Transplantation, Heart-Lung Transplantation, Liver-Lung Transplantation, and Combined Hematopoietic Stem Cell Transplantation and Lung Transplantation

Clinics in Chest Medicine, 2017
Lung transplantation (LTx) has evolved to represent the therapy of choice for many patients with end-stage lung diseases. Appropriate candidate selection for LTx is an important determinant of a positive outcome from transplantation. Posttransplantation survival has steadily improved, but long-term survival continues to be a challenge with a median ...
Shruti, Gadre, Jason, Turowski, Marie, Budev   +2 more
openaire   +2 more sources

Lung transplantation

Chest Surgery Clinics of North America, 2003
In this summary of his verbal communication, G.A. Patterson develops the reasons which have prompted the Toronto group to perform unilateral or bilateral lung transplantations. The author also briefly presents the results obtained by his group in these two types of lung transplantation and in heart-lung transplantation.
openaire   +2 more sources

Pediatric Lung Transplantation

Transplantation Proceedings, 2005
Pediatric lung transplantation (LT) was started in Spain in 1996 at our institution. We compare the results of pediatric LT with those in adult patients.A retrospective review of LT patients from 1993 to 2003 included demographic donor and recipient data, pulmonary function, gas exchange parameters, complications, episodes of rejection and pneumonia ...
A, Alvarez, F J, Algar, F, Santos, R, Lama, C, Baamonde, F, Cerezo, A, Salvatierra   +6 more
openaire   +2 more sources

The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients.

The Journal of Heart and Lung Transplantation, 2022
A. Velleca, M. Shullo, K. Dhital, E. Azeka, Monica Colvin, E. Depasquale, M. Farrero, L. García-Guereta, G. Jamero, K. Khush, J. Lavee, S. Pouch, J. Patel, C.J. Michaud, M. Shullo, S. Schubert, A. Angelini, L. Carlos, S. Mirabet, J. Patel, M. Pham, S. Urschel, Kyung-Hee Kim, S. Miyamoto, S. Chih, K. Daly, P. Grossi, Doug Jennings, In-cheol Kim, Hoong Sern Lim, Tara Miller, L. Potena, A. Velleca, H. Eisen, L. Bellumkonda, L. Danziger-Isakov, F. Dobbels, M. Harkess, Daniel Kim, Haifa Lyster, Y. Peled, Z. Reinhardt   +41 more
semanticscholar   +1 more source

Pediatric Lung Transplantation

Pediatric Clinics of North America, 2010
Lung transplantation is an accepted therapy for selected pediatric patients with severe end-stage vascular or parenchymal lung disease. Collaboration between the patients' primary care physicians, the lung transplant team, patients, and patients' families is essential.
M, Solomon, H, Grasemann, S, Keshavjee
openaire   +2 more sources

Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation.

The Journal of Heart and Lung Transplantation, 2019
BACKGROUND The application of mesenchymal stromal cell (MSC)-based therapy during ex vivo lung perfusion (EVLP) could repair injured donor lungs before transplantation.
D. Nakajima, Yui Watanabe, A. Ohsumi, M. Pipkin, Manyin Chen, P. Mordant, T. Kanou, Tomohito Saito, R. Lam, R. Coutinho, L. Caldarone, S. Juvet, T. Martinu, R. Iyer, J. Davies, D. Hwang, T. Waddell, M. Cypel, Mingyao Liu, S. Keshavjee   +19 more
semanticscholar   +1 more source

Pediatric lung transplantation

Seminars in Pediatric Surgery, 2006
Lung transplantation in children is an effective treatment for end-stage pulmonary disease after all medical therapy has failed. It requires a huge investment in resources and absolute commitment on the part of the parents and patients. In spite of all these efforts and expense, the results with pediatric lung transplantation are the worst of all solid
openaire   +3 more sources